Neta Barashi Selected Research

streptococcal polysaccharide type III group B

2/2020	A blocking monoclonal antibody to CCL24 alleviates liver fibrosis and inflammation in experimental models of liver damage.
1/2019	Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neta Barashi Research Topics

Disease

4	Inflammation (Inflammations) 02/2020 - 07/2013
2	Fibrosis (Cirrhosis) 02/2020 - 01/2019
1	Non-alcoholic Fatty Liver Disease 02/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 02/2020
1	Pneumonia (Pneumonitis) 01/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019
1	Systemic Scleroderma (Systemic Sclerosis) 01/2019
1	Neoplasms (Cancer) 01/2018
1	Neuroblastoma 01/2018
1	Carcinogenesis 09/2013
1	Chronic Hepatitis (Chronic Active Hepatitis) 07/2013
1	Hepatitis 07/2013

Drug/Important Bio-Agent (IBA)

2	Monoclonal AntibodiesIBA 02/2020 - 01/2019
2	streptococcal polysaccharide type III group BIBA 02/2020 - 01/2019
1	Choline (Choline Chloride)IBA 02/2020
1	CollagenIBA 02/2020
1	EnzymesIBA 02/2020
1	Methionine (L-Methionine)FDA Link 02/2020
1	Proteins (Proteins, Gene)FDA Link 02/2020
1	ChemokinesIBA 02/2020
1	Therapeutic UsesIBA 02/2020
1	Chemokine CCL24IBA 01/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2019
1	4-fluorobenzoyl-TN-14003IBA 01/2018
1	Cyclin D1IBA 01/2018
1	Chemokine ReceptorsIBA 09/2013
1	Adenosine Triphosphate (ATP)IBA 07/2013
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 07/2013
1	LectinsIBA 07/2013
1	Concanavalin AIBA 07/2013

Therapy/Procedure

1	Therapeutics 01/2018